Literature DB >> 17872459

Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation: synergism of TLR2 and TLR4.

Masakazu Shinohara1, Ken-ichi Hirata, Tomoya Yamashita, Tomofumi Takaya, Naoto Sasaki, Rio Shiraki, Tomomi Ueyama, Noriaki Emoto, Nobutaka Inoue, Mitsuhiro Yokoyama, Seinosuke Kawashima.   

Abstract

OBJECTIVE: Atherosclerosis is now considered as a chronic inflammatory disease, and inflammation is closely related to immune systems, which consist of innate-immunity and adaptive-immunity. Recently, toll-like receptors (TLRs) have been identified as key components of innate-immunity. We examined the role of local expressions of TLRs at the vessel wall in atherosclerosis. METHODS AND
RESULTS: We transfected cDNA encoding human TLR2 and TLR4 into the carotid arterial vessel wall of rabbits fed high-cholesterol diets with the use of HVJ-liposome. The rabbits were transfected with (1) pCMV-beta-gal, (2) empty vector, (3) TLR2, (4) TLR4, (5) TLR2+4. X-gal staining and immunohistochemical analysis showed that the transfected plasmids were mainly expressed in the media. Neither TLR2 nor TLR4 transfection induced significant augmentation of atherosclerosis. Transfection of TLR2- and TLR4-containing HVJ synergistically accelerated atherosclerosis and increased expressions of vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and MCP-1. Moreover, transfection of TLR2 and TLR4 resulted in synergistic activation of NF-kappaB at the vessel wall in vivo, and in vascular smooth muscle cells in vitro.
CONCLUSIONS: Expressions of both TLR2 and TLR4 at the vessel wall synergistically accelerated atherosclerosis. The present study revealed the role of TLRs expressed locally at the vessel wall in the early stage of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17872459     DOI: 10.1161/ATVBAHA.106.139253

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  24 in total

Review 1.  Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.

Authors:  QiQuan Huang; Richard M Pope
Journal:  J Leukoc Biol       Date:  2010-05-19       Impact factor: 4.962

2.  Polymicrobial sepsis and endotoxemia promote microvascular thrombosis via distinct mechanisms.

Authors:  K N Patel; S H Soubra; F W Lam; M A Rodriguez; R E Rumbaut
Journal:  J Thromb Haemost       Date:  2010-03-12       Impact factor: 5.824

Review 3.  Toll-like receptor-4 and lipoprotein accumulation in macrophages.

Authors:  Yury I Miller; Soo-Ho Choi; Longhou Fang; Richard Harkewicz
Journal:  Trends Cardiovasc Med       Date:  2009-10       Impact factor: 6.677

4.  TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase.

Authors:  Tadaaki Nakashima; Seiji Umemoto; Koichi Yoshimura; Susumu Matsuda; Shinichi Itoh; Tomoaki Murata; Tohru Fukai; Masunori Matsuzaki
Journal:  Hypertens Res       Date:  2015-04-09       Impact factor: 3.872

5.  TLR4 regulates vascular smooth muscle cell proliferation in hypertension via modulation of the NLRP3 inflammasome.

Authors:  Hui-Meng Qi; Qin Cao; Qiang Liu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

6.  Toll-like receptors and myocardial ischemia/reperfusion, inflammation, and injury.

Authors:  David J Kaczorowski; Atsunori Nakao; Kenneth R McCurry; Timothy R Billiar
Journal:  Curr Cardiol Rev       Date:  2009-08

7.  Blueprints of signaling interactions between pattern recognition receptors: implications for the design of vaccine adjuvants.

Authors:  Kim Timmermans; Theo S Plantinga; Matthijs Kox; Michiel Vaneker; Gert Jan Scheffer; Gosse J Adema; Leo A B Joosten; Mihai G Netea
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

8.  Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice.

Authors:  Mohan R Dasu; Samuel Park; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Endocrinology       Date:  2009-04-23       Impact factor: 4.736

Review 9.  Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases.

Authors:  Elaine Lin; Jane E Freedman; Lea M Beaulieu
Journal:  Cardiovasc Ther       Date:  2009       Impact factor: 3.023

10.  Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.

Authors:  Mohan R Dasu; Sridevi Devaraj; Samuel Park; Ishwarlal Jialal
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.